Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1) is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the Department of Defense Neurofibromatosis Research Program (NFRP)
Grant: W81XWH-17-1-0193
the Department of Defense Neurofibromatosis Research Program (NFRP)
Grant: RF1 AG059088
National Institutes of Health
Grant: 1RF1AG059088-01
Effects of apoE Isoform, Sex and Diet on Insulin Regulation in Brain
FWCI
0.63
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords